Dual therapy with Atazanavir/ritonavir plus Raltegravir versus triple therapy with Atazanavir/ritonavir plus Tenofovir-Emtricitabine after failure to an NNRTI regimen: 48-week results of the randomized pilot study ARTE trial

María Inés Figueroa, Omar Sued, Carina Cesar, Patricia Patterson, Cleyton Yamamoto, Valeria Fink, Norma Luna, Antonio Camiro-Zúñiga, Ana Gun, Pedro Cahn
doi: https://doi.org/10.1101/2022.07.08.22277426

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Back to top
Posted July 09, 2022.
Download PDF
Data/Code
Email
Dual therapy with Atazanavir/ritonavir plus Raltegravir versus triple therapy with Atazanavir/ritonavir plus Tenofovir-Emtricitabine after failure to an NNRTI regimen: 48-week results of the randomized pilot study ARTE trial
María Inés Figueroa, Omar Sued, Carina Cesar, Patricia Patterson, Cleyton Yamamoto, Valeria Fink, Norma Luna, Antonio Camiro-Zúñiga, Ana Gun, Pedro Cahn
medRxiv 2022.07.08.22277426; doi: https://doi.org/10.1101/2022.07.08.22277426
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area